7-45686221-T-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_021116.4(ADCY1):c.2327+6T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000539 in 1,611,554 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_021116.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADCY1 | NM_021116.4 | c.2327+6T>A | splice_region_variant, intron_variant | ENST00000297323.12 | NP_066939.1 | |||
ADCY1 | XM_005249584.4 | c.2327+6T>A | splice_region_variant, intron_variant | XP_005249641.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADCY1 | ENST00000297323.12 | c.2327+6T>A | splice_region_variant, intron_variant | 1 | NM_021116.4 | ENSP00000297323.7 |
Frequencies
GnomAD3 genomes AF: 0.00298 AC: 454AN: 152114Hom.: 4 Cov.: 33
GnomAD3 exomes AF: 0.000672 AC: 167AN: 248334Hom.: 3 AF XY: 0.000409 AC XY: 55AN XY: 134314
GnomAD4 exome AF: 0.000280 AC: 409AN: 1459322Hom.: 4 Cov.: 33 AF XY: 0.000247 AC XY: 179AN XY: 725714
GnomAD4 genome AF: 0.00302 AC: 460AN: 152232Hom.: 4 Cov.: 33 AF XY: 0.00308 AC XY: 229AN XY: 74438
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 23, 2017 | c.2327+6T>A in intron 13 of ADCY1: This variant is not expected to have clinical significance because it has been identified in 0.84% (86/10252) of African chro mosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.or g; dbSNP rs75860455). - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 19, 2017 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 22, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | - - |
ADCY1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 05, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at